iProov is a small British biometric authentication company that is currently working with the NHS to provide secure login for the NHS Digital app. They are also working with the Home Office for the EU Settlement Scheme and with a range of other high-profile international customers who deploy their technology, including the US Department for Homeland Security, the Singapore government, the Australian government, and the Eurostar.

However, most recently, the company has very much been at the centre of a lot of nationwide debate around the introduction of Covid status certificates and the interoperability of vaccine passports internationally. This is due to the fact that in January this year, iProov announced plans to develop technology for vaccine certificates, having received a grant from Innovate UK to fund the pilot project.

Andrew Bud CBE is the Founder and CEO of face biometrics firm iProov. He is also the Chair of the Mobile Ecosystem Forum (MEF), the global trade association of the mobile content and applications industry. I invited him on the podcast o talk about the role that biometrics will play in a post-Covid world in wide a range of industries.

We also discuss how Covid status certificates will be integrated into public life and the developing conversation around their use.